BrahMos WORLD INDIA MADHYA PRADESH BHOPAL WTN SPECIAL GOSSIP CORNER RELIGION SPORTS BUSINESS FUN FACTS ENTERTAINMENT LIFESTYLE TRAVEL ART & LITERATURE SCIENCE & TECHNOLOGY HEALTH EDUCATION DIASPORA OPINION & INTERVIEW RECIPES DRINKS BIG MEMSAAB 2017 BUDGET 2017 FUNNY VIDEOS VIRAL ON WEB PICTURE STORIES Mahakal Ke Darshan
WTN HINDI ABOUT US PRIVACY POLICY SITEMAP CONTACT US
logo
Breaking News

Removal of old cells may delay onset of osteoarthritis

Sunday - June 11, 2017 2:54 pm , Category : HEALTH
 Removal of old cells may delay onset of osteoarthritis
Removal of old cells may delay onset of osteoarthritis

Seoul June 11 (IANS) Selective removal of old cells that are accumulated in our joints as we age may significantly contribute in delaying the onset of age-related degenerative joint conditions such as osteoarthritis researchers have found.

The findings published in the journal Nature Medicine suggest that the selective removal of Senescent cells (SnCs) from joints could reduce the development of post-traumatic osteoarthritis and allow new cartilage to grow and repair joints.

SnCs accumulate with age in many vertebrate tissues and are present at sites of age-related pathology.

Although SnC cells play an essential role in wound healing and injury repair they often are not cleared from knee and cartilage tissue after an injury thereby contributing to the development of osteoarthritis.

They may also promote cancer incidence in tissues the researchers said.

The study may provide new insights into therapies targeting SnCs for the treatment of trauma and age-related degenerative joint disease said Chaekyu Kim from the Ulsan National Institute of Science and Technology (UNIST) in South Korea.

The study also presented a novel pharmacologic candidate that alleviates age-related osteoarthritis by selectively destroying SnCs.

For the study the team took both younger and older mice and cut their anterior cruciate ligaments (ACL) to minic injury. They then administered injections of an experimental drug named UBX0101 to selectively remove SnCs after anterior cruciate ligament transection (ACLT) surgery.

The results showed that aged mice did not exhibit signs of cartilage regeneration after treatment with UBX0101 injections

According to the research team the relevance of their findings to human disease was validated using chondrocytes isolated from arthritic patients.

--IANS
rt/pgh/vt